Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.
about
Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonismβ1 Integrins as Therapeutic Targets to Disrupt Hallmarks of CancerLiver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARFIntegrin α9β1 in airway smooth muscle suppresses exaggerated airway narrowing.Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN.Inhibition of breast cancer growth and metastasis by a biomimetic peptide.Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cellsIntegrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasisImportance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesisPolydom/SVEP1 is a ligand for integrin α9β1.Improving the angiogenic potential of collagen matrices by covalent incorporation of Astragalus polysaccharidesPreimplantation factor (PIF) promoting role in embryo implantation: increases endometrial integrin-α2β3, amphiregulin and epiregulin while reducing betacellulin expression via MAPK in decidua.Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion.Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.The lymphatic system and pancreatic cancer.Priming Endothelial Cells With a Melanoma-Derived Extracellular Matrix Triggers the Activation of αvβ3/VEGFR2 Axis.Vascular endothelial growth factor A promotes vaccinia virus entry into host cells via activation of the Akt pathway.Notch-mediated induction of N-cadherin and α9-integrin confers higher invasive phenotype on rhabdomyosarcoma cellsIntegrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition.Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma.hMSC-Derived VEGF Release Triggers the Chemoattraction of Alveolar Osteoblasts.Integrins in Wound Healing.Astrocytes spatially restrict VEGF signaling by polarized secretion and incorporation of VEGF into the actively assembling extracellular matrix.Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Aging.Vascular Endothelial Growth Factor-A Exerts Diverse Cellular Effects via Small G Proteins, Rho and Rap.Integrin α9 Suppresses Hepatocellular Carcinoma Metastasis by Rho GTPase Signaling.
P2860
Q24303934-4EC07387-99F8-4F4C-AFC8-78C34C0ABA63Q26774789-524839F3-F3EC-4D04-BDD3-46505EB341D5Q28550609-13C296F1-0297-43D1-8430-041611E87752Q30525167-BA270545-0AE0-4264-9608-47895977ECDDQ34251088-850F4D66-E630-42EA-AE81-42FBE0CE238DQ34545644-D41757E5-83AF-4D93-845A-4E21A810A06CQ34914039-B4259F4B-D260-4A70-AB1E-3B56CA9D1A5BQ35673201-40CDDD72-CD2D-4939-ADFB-CE39BD9DA05AQ35810928-0A12C435-579E-4042-BF9B-030EF7ABCC0DQ36048205-F314107D-5A8F-455C-AFD3-0B548F6B12C0Q36127186-661092DC-F0A5-48D4-A8B5-2C66D9E5A9B3Q36154184-881AE06D-5375-4B25-8A11-20B765C64519Q36240047-457CE7BB-4168-4B67-8DE5-90B455782CD5Q36691508-E4F291BB-771A-404D-B608-A8F0DAEF1A0CQ37093692-D7C81B4D-0E9C-4FD6-A6A6-295EAC1D4138Q38418286-56EF0BB7-B20C-413A-9B80-6B2C6DC8400CQ38661111-0426AAAC-5171-4889-ABB7-6CCC0BBDF302Q38689578-A8EABA69-81B2-4655-A04E-45FB07B36C85Q38758000-DA45019C-62AB-4D51-B79F-798E05EAA8F4Q39220397-FA1CB014-DEAB-4C36-93B0-10711460F32DQ39279019-07704FCA-732B-4CF1-AFB7-79352CF61672Q39389243-A8055CC9-378F-47BC-A764-E25268DA44ECQ40294268-E1EBD3E0-C189-4A34-AA3B-668DE3D7F906Q40667963-D667BC6F-4A83-40EC-A9FC-82F61ACA8E66Q43049043-628EFA55-9D93-4281-9BE1-CB15DF07D1A3Q50239732-AC7C13F7-9ACD-4129-8CC9-429B4E51C223Q51760150-5782D5E1-1C16-46F1-98BC-7EA25FFA1482Q52719147-D726FBFD-9F37-4AD4-91F6-1BE24E3ACCFCQ55312030-BD9EBB76-FA7E-4C02-A1CB-E76F66806444
P2860
Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vascular endothelial growth fa ...... {alpha}9{beta}1 binding site.
@ast
Vascular endothelial growth fa ...... {alpha}9{beta}1 binding site.
@en
type
label
Vascular endothelial growth fa ...... {alpha}9{beta}1 binding site.
@ast
Vascular endothelial growth fa ...... {alpha}9{beta}1 binding site.
@en
prefLabel
Vascular endothelial growth fa ...... {alpha}9{beta}1 binding site.
@ast
Vascular endothelial growth fa ...... {alpha}9{beta}1 binding site.
@en
P2093
P2860
P356
P1476
Vascular endothelial growth fa ...... {alpha}9{beta}1 binding site.
@en
P2093
Nicholas E Vlahakis
Saji Oommen
Shiv K Gupta
P2860
P304
P356
10.1074/JBC.M110.175158
P407
P577
2010-11-11T00:00:00Z